局部肝素治疗烧伤的系统综述与随机对照研究荟萃分析
该系统综述与荟萃分析纳入7项随机对照试验共503例烧伤患者,评估局部肝素(TH)的疗效。结果显示TH可使局部伤口感染减少60%(RR=0.40,P<.01)并降低视觉模拟评分疼痛得分(MD=-3.34,P<.01),但对镇痛药使用、出血、脓毒症、住院时间和死亡率无显著影响。排除离群值后疼痛改善消失,所有研究存在高偏倚风险。
要点
- 局部肝素可减少烧伤患者局部伤口感染60%(RR=0.40,P<.01)。
- 局部肝素降低VAS疼痛评分(MD=-3.34,P<.01),但排除离群值后不显著。
- 镇痛药使用、出血、脓毒症、住院时间和死亡率无显著差异。
核心结论
- 局部肝素可减少烧伤患者疼痛和局部伤口感染,但对其他结局无显著影响。
- 证据受高偏倚风险限制,需设计良好的随机试验确定更广泛的临床价值。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Scopus和Web of Science(2024年8月7日),仅纳入随机对照研究。
- 共纳入7项随机对照试验,503例患者(局部肝素组249例,对照组254例),使用R软件(版本4.4.1)进行统计分析。
主要发现
- 局部伤口感染减少60%(RR=0.40,P<.01)。
- VAS疼痛评分降低(MD=-3.34,P<.01),但排除离群值后疼痛改善不显著(MD=-4.17,P=.57)。
- 镇痛药使用(1-2次/天:RR=3.04,P=.68;3-4次/天:RR=0.06,P=.18)、出血(RR=5.06,P=.37)、脓毒症(RR=0.77,P=.40)、住院时间和死亡率(RR=0.13,P=.90)均无显著差异。
临床怎么用
- 局部肝素可能作为烧伤患者减少局部伤口感染和疼痛的辅助治疗选择。
- 需注意证据受高偏倚风险限制,临床应用应谨慎并结合个体情况。
局限性
- 所有研究存在高偏倚风险,尤其在结局测量和随机化方面。
- 排除离群值后疼痛改善不显著,提示疼痛结果不稳定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Burns are associated with significant inflammation and pain. Topical agents like heparin can modulate these processes and improve outcomes. Our study aims to evaluate the effectiveness of using topical heparin (TH) in patients with burns. On August 7, 2024, we conducted a literature search on PubMed, Scopus, and Web of Science. Only randomized controlled studies were included. Data were extracted on analgesic drug usage, bleeding events, sepsis, visual analog scale pain scores, length of hospital stay, and mortality. Statistical analysis was performed using R software (version 4.4.1), heterogeneous data. Seven randomized controlled trials (503 patients; topical heparin: 249, control: 254) were included. Analgesic use (1-2 times/day: RR = 3.04, P = .68; 3-4 times/day: RR = 0.06, P = .18), bleeding (RR = 5.06, P = .37), sepsis (RR = 0.77, P = .40), hospital stay, and mortality (RR = 0.13, P = .90) showed no significant differences. Topical heparin reduced local wound infections by 60% (RR = 0.40, P < .01) and lowered Visual Analog Scale pain scores (MD = -3.34, P < .01). However, sensitivity analysis excluding an outlier nullified the pain reduction (MD = -4.17, P = .57). All studies had a high risk of bias, especially in outcome measurement and randomization. Topical heparin reduces pain and local wound infections in burn patients without having an impact on other outcomes. Evidence is limited by a high risk of bias. Well-designed randomized trials are needed to determine its broader clinical value.
引用
- Nassar M, Mohamed MI, Shahid M, et al. Topical Heparin in Burns: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Burn Care Res. 2026. PMID: 40884473. doi:10.1093/jbcr/iraf168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。